Time reports five million Americans using compounded GLP-1s as peptide list looms
A July FDA committee recommended allowing compounding of six peptides, a decision the agency has not yet adopted, while telehealth tirzepatide sells for $250 a month.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 7 08:00 ETSource: Time Magazine
The wire
- 01Time reports a Gallup poll finding roughly 5 million US adults use compounded GLP-1s; nearly one in five of the 11% taking GLP-1s for weight loss sources them from compounders.
- 02One patient profiled paid $250 monthly for compounded tirzepatide with B12 versus $399 through LillyDirect, then developed brain fog, nausea and diarrhea after her telehealth site switched pharmacies.
- 03A July FDA advisory committee recommended permitting compounding of six peptides; the agency has not decided whether to adopt it. Lilly says it is the only lawful US supplier of tirzepatide, with patents to 2036.
From the source
Read at time.comCompounding Pharmacies for Weight-Loss Drugs Are Booming. Should You Trust Them?
Before the pandemic, Diane Kinkade lost weight with diet and exercise. But by 2026, she decided she needed to try something else. She had prediabetes and high blood pressure , in addition to being overweight, but her doctor declined to prescribe her a GLP-1 weight-loss medication , saying he thought the side effects outweighed the benefits. So she asked around and found a telehealth site that seem
